Pancreatic Neoplasm Clinical Trials

14 recruiting

Pancreatic Neoplasm Trials at a Glance

53 actively recruiting trials for pancreatic neoplasm are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Phase 2 with 13 trials, with the heaviest enrollment activity in Shanghai, London, and Seoul. Lead sponsors running pancreatic neoplasm studies include National Cancer Institute (NCI), Nuvance Health, and Ruijin Hospital.

Browse pancreatic neoplasm trials by phase

Treatments under study

About Pancreatic Neoplasm Clinical Trials

Looking for clinical trials for Pancreatic Neoplasm? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pancreatic Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pancreatic Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 53 trials

Recruiting
Not Applicable

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

Pancreatic CancerLiver MetastasesPancreatic Neoplasm
University of Aarhus200 enrolled3 locationsNCT05428358
Recruiting
Phase 1

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Pancreatic NeoplasmMetastatic Pancreatic Neuroendocrine TumorStage III Pancreatic Neuroendocrine Tumor AJCC v8+2 more
National Cancer Institute (NCI)24 enrolled10 locationsNCT05687123
Recruiting
Not Applicable

Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens

Pancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Neoplasms+1 more
ARTIDIS AG200 enrolled1 locationNCT07542041
Recruiting

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Stomach NeoplasmsMesotheliomaPancreatic Neoplasms+2 more
National Cancer Institute (NCI)1,000 enrolled1 locationNCT01950572
Recruiting

The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer

Pancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IVPancreatic Neoplasms+1 more
Nuvance Health200 enrolled1 locationNCT04406831
Recruiting

A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals

Pancreatic Neoplasms
Nuvance Health200 enrolled1 locationNCT03250078
Recruiting

A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus

Pancreatic CancerDiabetes MellitusPancreatic Neoplasms
Nuvance Health800 enrolled2 locationsNCT03937453
Recruiting
Not Applicable

Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia

Pancreatic NeoplasmsPancreatoduodenectomyHypotension
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran206 enrolled1 locationNCT06953193
Recruiting
Phase 2

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Pancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer
Ruijin Hospital50 enrolled1 locationNCT07504471
Recruiting
Phase 3

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Pancreatic CarcinomaPancreatic Neoplasm
SWOG Cancer Research Network274 enrolled118 locationsNCT06807437
Recruiting

Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors

Pancreatic Neuroendocrine TumorSolid Pancreatic Neoplasms
Fudan University1,000 enrolled2 locationsNCT05847855
Recruiting
Not Applicable

Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study

Pancreatic Neoplasm
Ohio State University Comprehensive Cancer Center84 enrolled1 locationNCT05961982
Recruiting
Not Applicable

EUS-guided RFA for Pancreatic Neoplasms

Pancreatic Neoplasms
Chinese University of Hong Kong30 enrolled1 locationNCT03218345
Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Breast CancerLiver CancerEsophageal Cancer+35 more
UMC Utrecht8,000 enrolled18 locationsNCT04075305
Recruiting

Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts

Pancreas CancerPancreatic Neoplasms
Johns Hopkins University5,000 enrolled1 locationNCT04473794
Recruiting
Phase 1

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Ovarian NeoplasmsStomach NeoplasmsLung Neoplasms+5 more
National Cancer Institute (NCI)100 enrolled1 locationNCT06885697
Recruiting

MRE for Diagnosis of Pancreatic Masses

Magnetic Resonance ImagingPancreatic Neoplasm
Yu Shi200 enrolled1 locationNCT06526442
Recruiting

Endocrine-exocrine Functions and Prognosis After Pancreatectomy

Pancreatic Neoplasm
National Taiwan University Hospital3,500 enrolled1 locationNCT07396662
Recruiting
Phase 2

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Pancreatic NeoplasmDuodenal Neoplasm
Masonic Cancer Center, University of Minnesota78 enrolled1 locationNCT06411795
Recruiting

Delayed Gastric Emptying After Pancreatic Surgery

Pancreatic Neoplasm
National Taiwan University Hospital3,500 enrolled1 locationNCT07382791